Perkins Coie Trust Co - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Perkins Coie Trust Co ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53
-57.3%
1780.0%0.00%
Q2 2023$124
-21.5%
1780.0%0.00%
Q1 2023$158
-24.0%
1780.0%0.00%
Q4 2022$208
-79.2%
1780.0%0.00%
Q3 2022$1,0000.0%1780.0%0.00%
Q2 2022$1,0000.0%1780.0%0.00%
Q1 2022$1,0000.0%1780.0%0.00%
Q4 2021$1,0000.0%1780.0%0.00%
Q3 2021$1,000
-50.0%
1780.0%0.00%
-100.0%
Q2 2021$2,0000.0%1780.0%0.00%0.0%
Q1 2021$2,0000.0%1780.0%0.00%0.0%
Q4 2020$2,000
+100.0%
1780.0%0.00%
Q3 2020$1,000
-50.0%
1780.0%0.00%
-100.0%
Q2 2020$2,000
+100.0%
1780.0%0.00%0.0%
Q1 2020$1,000
-66.7%
1780.0%0.00%0.0%
Q4 2019$3,000
+50.0%
1780.0%0.00%0.0%
Q3 2019$2,0000.0%1780.0%0.00%0.0%
Q2 2019$2,0000.0%1780.0%0.00%0.0%
Q1 2019$2,0000.0%1780.0%0.00%0.0%
Q4 2018$2,0000.0%1780.0%0.00%0.0%
Q3 2018$2,0000.0%1780.0%0.00%0.0%
Q2 2018$2,0000.0%1780.0%0.00%0.0%
Q1 2018$2,0000.0%1780.0%0.00%0.0%
Q4 2017$2,0000.0%1780.0%0.00%0.0%
Q3 2017$2,000
+100.0%
1780.0%0.00%0.0%
Q2 2017$1,000
-50.0%
1780.0%0.00%0.0%
Q1 2017$2,0001780.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$20,462,0006.02%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$18,315,0003.89%
NEXTHERA CAPITAL LP 263,600$3,018,0001.54%
SPHERA FUNDS MANAGEMENT LTD. 385,301$4,412,0000.86%
RA Capital Management 354,200$4,056,0000.50%
DAFNA Capital Management LLC 35,977$412,0000.35%
Boxer Capital, LLC 138,331$1,584,0000.35%
SABBY MANAGEMENT, LLC 238,907$2,735,0000.15%
Monashee Investment Management LLC 31,500$361,0000.14%
Lombard Odier Asset Management (USA) Corp 100,000$1,145,0000.11%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders